EPS Bio Technology Corp. (4183.TWO)

TWD 22.65

(0.22%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 470.16 Million 463.45 Million 480.27 Million 477.59 Million 459.34 Million
Cost of Revenue 354.45 Million 356.03 Million 359.61 Million 342.84 Million 348.05 Million
Gross Profit 115.71 Million 107.41 Million 120.66 Million 134.75 Million 111.28 Million
Operating Expenses 90.63 Million 88.79 Million 86.4 Million 89.3 Million 83.55 Million
Selling, General and Administrative Expenses 57.56 Million 57.91 Million 54.13 Million 58.92 Million 52.61 Million
Research and Development Expenses 33.83 Million 30.87 Million 32.27 Million 30.38 Million 30.94 Million
Other Expenses -607 Thousand 13.36 Million -7.44 Million -2.33 Million -
Cost and Expenses 445.24 Million 444.83 Million 446.02 Million 432.15 Million 431.61 Million
Operating Income 24.92 Million 32.19 Million 26.9 Million 43.65 Million 27.73 Million
Interest Expense 2.13 Million 2.13 Million 2.18 Million 2.29 Million 2.52 Million
Income Tax Expense 5.47 Million 2.09 Million 4.88 Million 8.37 Million 5.57 Million
Earnings before Tax 26.45 Million 27.45 Million 23.52 Million 40.07 Million 24.01 Million
Net Income 20.98 Million 25.36 Million 18.63 Million 31.7 Million 18.43 Million
Earnings Per Share Basic 0.88 1.07 0.78 1.33 0.77
Earnings Per Share Diluted 0.88 1.06 0.78 1.33 0.77
Weighted Average Shares Outstanding 23.8 Million 23.8 Million 23.8 Million 23.8 Million 23.8 Million
Weighted Average Shares Outstanding (Diluted) 23.87 Million 23.87 Million 23.89 Million 23.92 Million 23.88 Million
Gross Margin 0.25 0.23 0.25 0.28 0.24
EBIT Margin 0.09 0.11 0.09 0.13 0.09
Profit Margin 0.04 0.05 0.04 0.07 0.04
EBITDA 44.08 Million 49.5 Million 45.48 Million 61.48 Million 42.2 Million
Earnings Before Tax Margin 0.05 0.07 0.06 0.09 0.06

Income Statement Charts